Lana Dalal, - Pharmacist in El Cajon, CA

Lana Dalal, is a Pharmacist based in El Cajon, California. Lana Dalal is licensed to practice in California (license number 74615) and her current practice location is Walmart Pharmacy# 3524,605 Fletcher Pkwy, El Cajon, California. She can be reached at her office (for appointments etc.) via phone at (619) 440-0848.

NPI number for Lana Dalal is 1013452564 and her current mailing address is Walmart Pharmacy, 605 Fletcher Pkwy, El Cajon, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1013452564.

Contact Information

Lana Dalal,
Walmart Pharmacy# 3524,605 Fletcher Pkwy,
El Cajon, CA 92020
(619) 440-0848
Not Available

Healthcare Provider's Profile

Full NameLana Dalal
GenderFemale
SpecialityPharmacist
LocationWalmart Pharmacy# 3524,605 Fletcher Pkwy, El Cajon, California
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1013452564
  • Provider Enumeration Date: 12/19/2016
  • Last Update Date: 12/19/2016

Medical Identifiers

Medical identifiers for Lana Dalal such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013452564NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist 74615 (California)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Lana Dalal is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Lana Dalal,
Walmart Pharmacy, 605 Fletcher Pkwy,
El Cajon, CA 92020

Ph: () -
Lana Dalal,
Walmart Pharmacy# 3524,605 Fletcher Pkwy,
El Cajon, CA 92020

Ph: (619) 440-0848

News Archive

First detailed map of transcriptome and epitranscriptome for novel coronavirus (SARS-CoV-2)

A team of researchers has come out with the first detailed map of the transcriptome and epitranscriptome of the virulent SARS-CoV-2 that causes COVID-19 disease, the illness that has become a pandemic ravaging both developed and less developed countries of the world. The study, published in the journal Cell in April 2020, may assist in the development of new vaccines and therapeutics.

Resilience improves level of satisfaction in one's life

When confronted with adverse situations such as the loss of a loved one, some people never fully recover from the pain. Others, the majority, pull through and experiment how the intensity of negative emotions (e.g. anxiety, depression) grows dimmer with time until they adapt to the new situation. A third group is made up of individuals whose adversities have made them grow personally and whose life takes on new meaning, making them feel stronger than before.

Santarus enrolls 510 patients in Phase III clinical program for budesonide MMX

Santarus, Inc., a specialty biopharmaceutical company, today announced the completion of enrollment of 510 patients in a U.S. Phase III clinical study to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis. This is the second Phase III clinical study being conducted in collaboration with Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA, as part of the budesonide MMX Phase III clinical program for U.S. registration.

HIV-positive people with severe immunosuppression, APOE4 gene may have increased risk for dementia

People living with the human immunodeficiency virus (HIV) who have a history of severe immunosuppression and at least one copy of the Alzheimer's disease-related gene variant APOE4, might see a compounded adverse effect on the circuitry that impacts memory.

Read more News

› Verified 3 days ago


Pharmacist in El Cajon, CA

Nada Ghaith, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 11981 Via Hacienda, El Cajon, CA 92019
Phone: 619-277-0331    
Claire Huynh, PHARM.D
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 2911 Jamacha Rd, El Cajon, CA 92019
Phone: 619-315-0016    
Fay Lui,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 605 Fletcher Pkwy, El Cajon, CA 92020
Phone: 619-440-0848    Fax: 619-440-4047
Hani Maroki, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1000 S Mollison Ave Unit 15, El Cajon, CA 92020
Phone: 619-792-8610    
Kwi Yeom Lee, PHARM.D.
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 300 N 2nd St, El Cajon, CA 92021
Phone: 619-219-5252    
Mr. Charles Harold Jones,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 2899 Jamacha Rd, El Cajon, CA 92019
Phone: 858-405-8377    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.